P3-11-3SUCCESSFUL TREATMENT IN A PATIENT WITH NEUROENDOCRINE TUMOR WHO DEVELOPED EVEROLIMUS-ASSOCIATED INTERSTITIAL PNEUMONIA

Satoshi Tamaru,Toshiro Mizuno,Akihiko Sawaki,Keiki Nagaharu,Haruna Sakaguchi,Hiroyasu Oda,Mikiya Ishihara,Yumiko Sugawara,Yoshiki Yamashita,Naoyuki Katayama

ANNALS OF ONCOLOGY（2014）

引用 0|浏览4

暂无评分

摘要

Background: Everolimus, a mammalian target of rapamycin (mTOR) inhibitor, is treated for well-differentiated Neuroendocrine Tumor (NET) and is known to induce interstitial pneumonia.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要